.webp)
Tirzepatide activates both GIP and GLP-1 receptors, two pathways involved in appetite regulation, digestion, insulin signaling, and blood-sugar control.
By acting on these pathways, tirzepatide may help reduce hunger, increase feelings of fullness, decrease food cravings, and make portion control easier, supporting steady weight-management progress when paired with healthy nutrition and lifestyle habits.
Vitamin B12 supports normal energy metabolism, red blood cell formation, and nervous-system health, providing added nutritional support within the formulation.
Treatment typically begins at a lower dose and may be increased gradually based on your tolerance, response, and treatment goals.
Patients may experience:
• Reduced appetite and hunger
• Feeling full sooner and for longer
• Fewer food cravings
• Improved portion control
• Progressive weight-management support
• Support for healthier metabolic and blood-sugar patterns
• B12 nutritional support
Results vary from person to person, and consistency with nutrition, activity, sleep, and treatment remains important.
Before starting Tirzepatide + B12, your medical prescriber will review your health history, medications, allergies, previous weight-management treatments, and treatment goals.
Be sure to discuss any history of pancreatitis, gallbladder disease, significant digestive problems, kidney concerns, diabetes-related eye disease, or thyroid cancer, including a personal or family history of medullary thyroid carcinoma or MEN2.
Let your provider know if you are pregnant, breastfeeding, planning pregnancy, taking medications that affect blood sugar or appetite, or have a known sensitivity to vitamin B12 or cobalt.
Your dose may be adjusted over time based on your tolerance, response, and progress.
Prescription required.